| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HLC.2018.03.007 |
| P8608 | Fatcat ID | release_7nw4lmmlyvaa3dcoxaspi2xz6e |
| P932 | PMC publication ID | 6150836 |
| P698 | PubMed publication ID | 29685716 |
| P50 | author | Faye L. Norby | Q55445198 |
| Aaron R. Folsom | Q71098091 | ||
| Susan R Heckbert | Q88077554 | ||
| P2093 | author name string | Alvaro Alonso | |
| Yasuhiko Kubota | |||
| P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
| Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications | Q26796244 | ||
| Homocysteine lowering with folic acid and B vitamins in vascular disease | Q28301516 | ||
| Homocysteine lowering and cardiovascular events after acute myocardial infarction | Q28301525 | ||
| B vitamin status and inflammatory markers | Q28645893 | ||
| Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias | Q28731901 | ||
| The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
| Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
| Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data | Q31137007 | ||
| Homocysteine and cardiovascular disease: cause or effect? | Q33987375 | ||
| Efficacy of folic acid supplementation in stroke prevention: a meta-analysis | Q34004505 | ||
| Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial | Q34544977 | ||
| Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings | Q34562725 | ||
| Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial | Q34582863 | ||
| Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial | Q34591566 | ||
| Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 | ||
| Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study | Q35070617 | ||
| Atrial fibrillation: current knowledge and future directions in epidemiology and genomics | Q35526930 | ||
| Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community | Q35575045 | ||
| Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study | Q36956679 | ||
| Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms | Q36956791 | ||
| Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis | Q36986116 | ||
| Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study | Q37199773 | ||
| Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study | Q37288459 | ||
| Atrial remodeling and atrial fibrillation: mechanisms and implications. | Q37609710 | ||
| Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study | Q38730259 | ||
| Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation | Q39559211 | ||
| High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion | Q43166741 | ||
| Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels | Q43636903 | ||
| Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction | Q44359631 | ||
| Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation? | Q45075933 | ||
| Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis | Q46210776 | ||
| Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation | Q46542941 | ||
| Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection | Q46982131 | ||
| Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. | Q51568729 | ||
| Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation. | Q53096927 | ||
| A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease | Q57268055 | ||
| Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease | Q69738760 | ||
| Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 | ||
| Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations | Q71852023 | ||
| Molecular mechanisms of myocardial remodeling | Q77918078 | ||
| Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC | Q80025376 | ||
| Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells | Q80260502 | ||
| Homocysteine inhibits potassium channels in human atrial myocytes | Q80654342 | ||
| P433 | issue | 4 | |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| atherosclerosis | Q12252367 | ||
| multiethnicity | Q111242702 | ||
| P304 | page(s) | 615-622 | |
| P577 | publication date | 2018-03-21 | |
| P1433 | published in | Heart, Lung and Circulation | Q15750094 |
| P1476 | title | Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis | |
| P478 | volume | 28 |
| Q89513185 | Association Between Homocysteine and Vascular Calcification Incidence, Prevalence, and Progression in the MESA Cohort |
| Q99570589 | Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation |
| Q61812239 | Vitamin B deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre |
Search more.